GlassScriptPhysician profile
James A Bynum
NPI 1578767174
$3,861.88
in general payments reported to CMS, 2019-2025
14 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $2,579 · 2021: $80.96 · 2022: $185 · 2023: $40.91 · 2024: $129 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,166.75 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Ascension |
| Foundation Fusion Solutions, LLC | $129.35 | 2024 | |
| Teleflex LLC | $122.40 | 2022 | |
| Arthrex, INC. | $120.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $83.69 | 2022-2025 | Iovera, Exparel |
| Baxter Healthcare | $57.58 | 2019-2021 | |
| Djo, LLC | $42.95 | 2025 | Cmf |
| Depuy Synthes Sales INC. | $27.13 | 2021 | |
| Ferring Pharmaceuticals INC. | $23.48 | 2019-2021 | |
| Linvatec Corporation | $23.22 | 2019 | |
| Acacia Pharma INC | $19.03 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.87 | 2019 | |
| Endo Pharmaceuticals INC. | $15.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bynum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.